Logo image of ALISP.PA

ISPD NETWORK (ALISP.PA) Stock Fundamental Analysis

EPA:ALISP - Euronext Paris - Matif - ES0109429037 - Common Stock - Currency: EUR

2.16  +0.02 (+0.93%)

Fundamental Rating

3

ALISP gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 63 industry peers in the Media industry. ALISP may be in some trouble as it scores bad on both profitability and health. ALISP has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALISP had negative earnings in the past year.
In the past year ALISP has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: ALISP reported negative net income in multiple years.
In multiple years ALISP reported negative operating cash flow during the last 5 years.
ALISP.PA Yearly Net Income VS EBIT VS OCF VS FCFALISP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.60%, ALISP is doing worse than 73.02% of the companies in the same industry.
ALISP's Return On Equity of -9.85% is on the low side compared to the rest of the industry. ALISP is outperformed by 79.37% of its industry peers.
With a Return On Invested Capital value of 2.85%, ALISP is not doing good in the industry: 63.49% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for ALISP is significantly above the industry average of 7.76%.
The last Return On Invested Capital (2.85%) for ALISP is well below the 3 year average (13.74%), which needs to be investigated, but indicates that ALISP had better years and this may not be a problem.
Industry RankSector Rank
ROA -0.6%
ROE -9.85%
ROIC 2.85%
ROA(3y)2.77%
ROA(5y)1.73%
ROE(3y)30.06%
ROE(5y)N/A
ROIC(3y)13.74%
ROIC(5y)14.58%
ALISP.PA Yearly ROA, ROE, ROICALISP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

Looking at the Operating Margin, with a value of 0.45%, ALISP is doing worse than 76.19% of the companies in the same industry.
ALISP's Operating Margin has declined in the last couple of years.
The Gross Margin of ALISP (31.54%) is worse than 77.78% of its industry peers.
In the last couple of years the Gross Margin of ALISP has declined.
Industry RankSector Rank
OM 0.45%
PM (TTM) N/A
GM 31.54%
OM growth 3Y-61.04%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.12%
GM growth 5Y-7.49%
ALISP.PA Yearly Profit, Operating, Gross MarginsALISP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

2

2. Health

2.1 Basic Checks

ALISP has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
ALISP has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALISP has more shares outstanding
Compared to 1 year ago, ALISP has a worse debt to assets ratio.
ALISP.PA Yearly Shares OutstandingALISP.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
ALISP.PA Yearly Total Debt VS Total AssetsALISP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 2.32 indicates that ALISP is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.32, ALISP is in the better half of the industry, outperforming 79.37% of the companies in the same industry.
ALISP has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of ALISP (1.10) is worse than 65.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Altman-Z 2.32
ROIC/WACC0.44
WACC6.41%
ALISP.PA Yearly LT Debt VS Equity VS FCFALISP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

ALISP has a Current Ratio of 0.95. This is a bad value and indicates that ALISP is not financially healthy enough and could expect problems in meeting its short term obligations.
ALISP has a Current ratio (0.95) which is comparable to the rest of the industry.
ALISP has a Quick Ratio of 0.95. This is a bad value and indicates that ALISP is not financially healthy enough and could expect problems in meeting its short term obligations.
ALISP has a Quick ratio of 0.95. This is comparable to the rest of the industry: ALISP outperforms 55.56% of its industry peers.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.95
ALISP.PA Yearly Current Assets VS Current LiabilitesALISP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

5

3. Growth

3.1 Past

ALISP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -116.55%.
The Revenue has grown by 11.47% in the past year. This is quite good.
The Revenue has been growing by 43.98% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-116.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.22%
Revenue 1Y (TTM)11.47%
Revenue growth 3Y13.88%
Revenue growth 5Y43.98%
Sales Q2Q%6.35%

3.2 Future

Based on estimates for the next years, ALISP will show a very strong growth in Earnings Per Share. The EPS will grow by 309.27% on average per year.
ALISP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.86% yearly.
EPS Next Y1075%
EPS Next 2Y309.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.17%
Revenue Next 2Y10.79%
Revenue Next 3Y6.89%
Revenue Next 5Y4.86%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALISP.PA Yearly Revenue VS EstimatesALISP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M
ALISP.PA Yearly EPS VS EstimatesALISP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 0.4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALISP. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 8.92, the valuation of ALISP can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALISP indicates a somewhat cheap valuation: ALISP is cheaper than 74.60% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ALISP to the average of the S&P500 Index (22.19), we can say ALISP is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 8.92
ALISP.PA Price Earnings VS Forward Price EarningsALISP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

ALISP's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ALISP is more expensive than 71.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 21.09
ALISP.PA Per share dataALISP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALISP's earnings are expected to grow with 309.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y309.27%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALISP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ISPD NETWORK

EPA:ALISP (6/20/2025, 7:00:00 PM)

2.16

+0.02 (+0.93%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)07-24 2024-07-24
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap32.16M
Analysts86.67
Price Target5.15 (138.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.81%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-12.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.92
P/S 0.21
P/FCF N/A
P/OCF N/A
P/B 6.7
P/tB N/A
EV/EBITDA 21.09
EPS(TTM)-0.03
EYN/A
EPS(NY)0.24
Fwd EY11.21%
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS10.48
BVpS0.32
TBVpS-0.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.6%
ROE -9.85%
ROCE 3.88%
ROIC 2.85%
ROICexc 4.45%
ROICexgc N/A
OM 0.45%
PM (TTM) N/A
GM 31.54%
FCFM N/A
ROA(3y)2.77%
ROA(5y)1.73%
ROE(3y)30.06%
ROE(5y)N/A
ROIC(3y)13.74%
ROIC(5y)14.58%
ROICexc(3y)49.31%
ROICexc(5y)157.45%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.7%
ROCE(5y)19.84%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-80.84%
ROICexc growth 5YN/A
OM growth 3Y-61.04%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.12%
GM growth 5Y-7.49%
F-Score1
Asset Turnover1.99
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Debt/EBITDA 2.7
Cap/Depr 123.02%
Cap/Sales 0.99%
Interest Coverage 1.02
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.95
Quick Ratio 0.95
Altman-Z 2.32
F-Score1
WACC6.41%
ROIC/WACC0.44
Cap/Depr(3y)110.41%
Cap/Depr(5y)81.37%
Cap/Sales(3y)0.96%
Cap/Sales(5y)0.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-116.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.22%
EPS Next Y1075%
EPS Next 2Y309.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.47%
Revenue growth 3Y13.88%
Revenue growth 5Y43.98%
Sales Q2Q%6.35%
Revenue Next Year11.17%
Revenue Next 2Y10.79%
Revenue Next 3Y6.89%
Revenue Next 5Y4.86%
EBIT growth 1Y-87.83%
EBIT growth 3Y-55.63%
EBIT growth 5YN/A
EBIT Next Year200%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-48.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-76.15%
OCF growth 3YN/A
OCF growth 5YN/A